Home · FSC 6505 Drugs And Biologicals · NSN 6505-01-385-6328
NSN 6505-01-385-6328 — Typhoid Vi Polysaccharide Vaccin
NIIN 01-385-6328 · unit of issue VI · AAC H (not stocked, central procurement (dispute)) · source of supply SMS
Buying rhythm
from 7 government buys since 2025
The government has bought this item about every 2 months (regular, gaps vary ±54%). Last buy Aug 31, 2026. If the rhythm holds, the next one falls between Sep 21, 2026 and Dec 20, 2026: a buy is due about now. 1 solicitation is open right now.
How well this works: for regular items, "next buy about one typical gap after the last, give or take 121 days" caught the actual next buy 42% of the time across 15,552 past buys, against 22% for a fixed "one year later" guess. A rhythm, not a schedule: DLA buys when stock and demand say so. Every item due for a buy now.
NSN 6505-01-385-6328 is the national stock number for a typhoid vi polysaccharide vaccin in federal supply class 6505 (Drugs And Biologicals). It cross-references to 2 manufacturer part numbers from 3 CAGE codes, including Sanofi Vaccines Us Inc., Cardinal Health 100, Inc., Cardinal Health 100, Inc Dba Bindley Western Tennessee Div; the primary is NDC49281-0790-20. The unit of issue is VI and the FLIS list price is $1,435.36.
The U.S. government has bought this item 23 times on record, 23 of them in the last 24 months, most recently on September 10, 2026 at $920.12 each from Mr Unlimited, LLC. The median unit price paid over 36 months is $927.23. 1 solicitation is open right now, the soonest due September 30, 2026 for 15 VI. No seller has confirmed stock of it here in the last 60 days; watching the number is free and the first listing triggers an alert.
2
part numbers from 3 CAGEs
1
open solicitation, all agencies
23
government buys in 24 months · median $927.23
0
sellers with confirmed stock
Cross-references
Part numbers filed against this stock number, with the manufacturer (CAGE) and the FLIS reference codes.
| Part number | CAGE | Manufacturer | Reference | Variation |
|---|---|---|---|---|
| NDC49281-0790-20 | 7V915 | Sanofi Vaccines Us Inc. | 3 · Design control (vendor) | 2 · Fully interchangeable |
| NDC49281-0790-20 | 1GAU9 | Cardinal Health 100, Inc. | 5 · Secondary reference | 9 · Reference only |
| NDC49281-0790-20 | 0A423 | Cardinal Health 100, Inc Dba Bindley Western Tennessee Div | 5 · Secondary reference | 9 · Reference only |
| TRIPHIM VI | 7V915 | Sanofi Vaccines Us Inc. | 5 · Secondary reference | 1 · Not fully interchangeable |
Government demand
Open DLA RFQs (DIBBS)
- SPE2DP26T5222 · 15 VI · due Sep 30, 2026 · N · AMSC G · DIBBS
What the government paid
| Date | Vendor | Qty | Unit cost | Amount | Buyer | Reference |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Mr Unlimited, LLC 3W8H0 | 16 | $920.12 | Dla | SPE2DP26V0926 | |
| Sep 10, 2026 | Mr Unlimited, LLC 3W8H0 | $14,722 | Dla | SPE2DP26V0926 » Award/Basic Package View | ||
| Aug 31, 2026 | Mr Unlimited, LLC 3W8H0 | 1 | $920.12 | Dla | SPE2DP26V0906 | |
| Aug 31, 2026 | Mr Unlimited, LLC 3W8H0 | $920 | Dla | SPE2DP26V0906 | ||
| Aug 4, 2026 | Mr Unlimited, LLC 3W8H0 | 10 | $920.12 | Dla | SPE2DP26V0857 | |
| Jun 29, 2026 | Mr Unlimited, LLC 3W8H0 | 4 | $920.12 | Dla | SPE2DP26V0807 | |
| Apr 17, 2026 | Mr Unlimited, LLC 3W8H0 | 5 | $920.12 | Dla | SPE2DP26V0629 | |
| Dec 15, 2025 | Mr Unlimited, LLC 3W8H0 | 1 | $920.20 | Dla | SPE2DP26V0241 | |
| Nov 7, 2025 | Cardinal Health, Inc. 00E55 | 14 | $920.21 | Dla | SPE2D926F0398 | |
| Sep 28, 2025 | Cardinal Health, Inc. 00E55 | 20 | $920.21 | Dla | SPE2D925F4658 | |
| Sep 18, 2025 | Cardinal Health, Inc. 00E55 | 1 | $920.21 | Dla | SPE2D925F4529 | |
| Sep 14, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 10 | $927.23 | Dla | SPE2DP25F119H | |
| Sep 9, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 2 | $927.23 | Dla | SPE2DP25F111R | |
| Sep 8, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 3 | $927.23 | Dla | SPE2DP25F110C | |
| Aug 28, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 7 | $927.23 | Dla | SPE2DP25F091J | |
| Aug 19, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 5 | $927.23 | Dla | SPE2DP25F069J | |
| Aug 18, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 3 | $927.23 | Dla | SPE2DP25F068W | |
| Aug 14, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 20 | $927.23 | Dla | SPE2DP25F062S | |
| Aug 11, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 7 | $927.23 | Dla | SPE2DP25F047M | |
| Aug 6, 2025 | Dms Pharmaceutical Group Inc 1UNB0 | 60 | $927.23 | Dla | SPE2DP25F035Z |
Sources: DLA DIBBS procurement history (unit cost), DLA award history, FPDS (all agencies), SAM.gov notices. 23 buys on record in total.
Sellers with confirmed stock
No seller has confirmed stock on this NSN in the last 60 days. Watch it and we will email you when one does, or request a quote on NDC49281-0790-20.
Listings appear here only while the seller has confirmed them within 60 days. Sellers: list this part free.
DLA management data
- FLIS unit price
- $1,435.36
- Unit of issue
- VI
- Acquisition advice
- H — Not stocked, central procurement (dispute)
- Source of supply
- SMS
- Shelf life code
- K
- Effective
- Oct 1, 2025
Item characteristics
- Part Name Assigned By Controlling Agency
- TYPHOID VI POLYSACCHARIDE VACCINE 10ML VIAL 20 DOSES
- Special Features
- ACELLULAR; 10 ML VIAL; 20 DOSES; STORE BETWEEN 2-8 DEG C.; SUBJECT TO DAMAGE BY FREEZING
About this page
An NSN is 13 digits: the 4-digit Federal Supply Class and the 9-digit NIIN. Cross-references come from the federal logistics record; demand from DLA DIBBS, SAM.gov and FPDS; ADs from the Federal Register. Refreshed nightly. Market Pulse shows the whole market.
Get the daily Market Pulse
New DLA RFQs, SAM.gov notices, yesterday's awards and FAA directives, weekday mornings. Free, one click to leave.